Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00124059 · ClinicalTrials.gov registry record · Phase 3
Quetiapine Fumarate (Seroquel) for the Treatment of Alcohol Dependence.
A Phase 3 study of Alcoholism, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 3
- Development phase
- 61
- Enrollment target
- 1
- Study location
NCT00124059: Completed Phase 3 study of Alcoholism, sponsored by University of Pennsylvania.
NCT00124059 is a Phase 3 study of Alcoholism that has completed, run by University of Pennsylvania. The registered enrollment target is 61 participants, below the 374-participant average among 65 other Alcoholism trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00124059, a Phase 3 study of Alcoholism, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 61 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether seroquel is effective in the treatment of type A and type B alcohol dependence.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Seroquel
Study Locations (1)
Pennsylvania
- University of Pennsylvania Treatment Research Center - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2003-03 |
| Est. Completion | 2005-10 |
| Phase | Phase 3 |
What the finished NCT00124059 record still lists
NCT00124059 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 61 participants, a relatively small participant target, below the 374-participant average among 65 other Alcoholism trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Alcoholism appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00124059 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00124059 about?
NCT00124059 is a clinical study titled "Quetiapine Fumarate (Seroquel) for the Treatment of Alcohol Dependence.". The purpose of this study is to determine whether seroquel is effective in the treatment of type A and type B alcohol dependence.
What is the current status of trial NCT00124059?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 61 participants. The study started on 2003-03. Estimated completion is 2005-10.
What conditions does trial NCT00124059 study?
This clinical trial studies the following conditions: Alcoholism.
What interventions are being tested in trial NCT00124059?
The interventions under investigation include: Placebo (DRUG), Seroquel (DRUG).
Who is sponsoring clinical trial NCT00124059?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00124059 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcoholism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00124059's enrollment target sits among peer trials
61 48th of 65 higher than 18 of 65 other Alcoholism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcoholism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Aripiprazole for Bipolar Disorder and Alcohol Use Disorder
COMPLETED · Phase 3
-
COMBINE (Acamprosate/Naltrexone)
COMPLETED · Phase 3
-
Naltrexone in AUD Reward Drinkers
RECRUITING · Phase 4
-
Characterization Imaging Instruments in Alcoholics and Non-Alcoholics
RECRUITING
-
Developing Functional Connectivity-Guided TMS for Alcohol Use Disorder
RECRUITING · NA
-
Alcohol and the Social Brain: an Alcohol-Administration Hyperscanning Study
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04115306 · 61 participants · Phase 1
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- NCT05070845 · 61 participants · Phase 2
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- NCT05187832 · 61 participants · Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- NCT05269316 · 61 participants · Phase 1
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia